Pharmena S.A. Cash Flow Conversion Efficiency

Latest as of September 2025: -0.078x

Pharmena S.A. cash flow conversion efficiency. Based on the latest financial reports, Pharmena S.A. (PHR) has a cash flow conversion efficiency ratio of -0.078x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-820.00K ≈ $-225.68K USD) by net assets (zł10.54 Million ≈ $2.90 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Pharmena S.A. (2008–2024)

Cash flow conversion efficiency of Pharmena S.A. from 2008 to 2024. This chart illustrates how Pharmena S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Pharmena S.A. (PHR) stock price for real-time trading data and today's change.

Pharmena S.A. Cash Flow Conversion Ratio Explained

Pharmena S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Pharmena S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Pharmena S.A. ranked by their cash flow conversion efficiency. Also see Pharmena S.A. stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Aban Offshore Limited NSE:ABAN	0.002x
Everland Public Company Limited BK:EVER	0.002x
Turbo Mech Bhd KLSE:5167	0.038x
Lions Bay Capital Inc V:LBI	-0.065x
Daekyo Co Ltd KO:019685	0.035x
Kwang Hee Self-Administered Real Estate KO:140910	-0.011x
Dinamik Isi Makina Yalitim Malzemeleri Sanayi ve Ticaret AS IS:DNISI	-0.013x
Clean Air Metals Inc V:AIR	-0.013x

Annual Cash Flow Conversion Efficiency for Pharmena S.A. (2008–2024)

The table below shows the annual cash flow conversion efficiency of Pharmena S.A. from 2008 to 2024. Review how much free cash does Pharmena S.A. generate to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	zł12.42 Million ≈ $3.42 Million	zł-2.53 Million ≈ $-696.57K	-0.204x	-113.71%
2023-12-31	zł22.23 Million ≈ $6.12 Million	zł33.03 Million ≈ $9.09 Million	1.486x	+654.93%
2022-12-31	zł-6.79 Million ≈ $-1.87 Million	zł1.82 Million ≈ $500.62K	-0.268x	-142.53%
2021-12-31	zł-5.12 Million ≈ $-1.41 Million	zł-3.23 Million ≈ $-887.57K	0.630x	-90.23%
2020-12-31	zł-348.00K ≈ $-95.77K	zł-2.24 Million ≈ $-617.31K	6.445x	+344.95%
2019-12-31	zł5.00 Million ≈ $1.37 Million	zł-13.15 Million ≈ $-3.62 Million	-2.631x	-241.00%
2018-12-31	zł1.94 Million ≈ $532.82K	zł3.61 Million ≈ $994.35K	1.866x	+973.60%
2017-12-31	zł3.56 Million ≈ $980.04K	zł619.00K ≈ $170.36K	0.174x	+208.74%
2016-12-31	zł5.94 Million ≈ $1.64 Million	zł-950.00K ≈ $-261.45K	-0.160x	+66.80%
2015-12-31	zł8.67 Million ≈ $2.39 Million	zł-4.17 Million ≈ $-1.15 Million	-0.481x	-9.53%
2014-12-31	zł13.08 Million ≈ $3.60 Million	zł-5.75 Million ≈ $-1.58 Million	-0.440x	-106.82%
2013-12-31	zł18.05 Million ≈ $4.97 Million	zł-3.84 Million ≈ $-1.06 Million	-0.213x	+52.93%
2012-12-31	zł8.98 Million ≈ $2.47 Million	zł-4.05 Million ≈ $-1.12 Million	-0.451x	-1213.85%
2011-12-31	zł16.45 Million ≈ $4.53 Million	zł666.91K ≈ $183.54K	0.041x	+159.65%
2010-12-31	zł15.91 Million ≈ $4.38 Million	zł-1.08 Million ≈ $-297.50K	-0.068x	-512.69%
2009-12-31	zł16.16 Million ≈ $4.45 Million	zł-179.22K ≈ $-49.32K	-0.011x	-437.74%
2008-12-31	zł15.78 Million ≈ $4.34 Million	zł-32.56K ≈ $-8.96K	-0.002x	--

About Pharmena S.A.

WAR:PHR Poland Biotechnology

Market Cap

$9.07 Million

zł32.97 Million PLN

Market Cap Rank

#27198 Global

#294 in Poland

Share Price

zł2.96

Change (1 day)

-0.67%

52-Week Range

zł2.55 - zł4.22

All Time High

zł28.01